Health
Asian nations scale back AstraZeneca rollout amid safety woes – The Japan Times
The moves may delay protection for the region amid concerns that the shot could trigger a rare and potentially deadly blood clotting condition.
Countries across the Asia Pacific are demurring on AstraZeneca PLCs COVID-19 vaccine, or restricting its use, in moves that may delay protection for the region amid concerns that the shot could trigger a rare and potentially deadly blood clotting condition.
After guiding against the vaccines use in people under 50 and saying that it didnt expect shipments from Europe to arrive on time, Australias government abandoned a pledge that everyone in the country would receive a first dose by October.
In…
-
General12 hours agoGymnastics club in Berwick shuts down following child safety complaint
-
Noosa News15 hours agoSanta drops in for carols
-
General17 hours agoCritically endangered orchid thrives as NSW Mid North Coast cemetery provides habitat refuge
-
Business18 hours agoHow to turn small weekly savings into life-changing wealth with ASX shares